Adverse drug reactions in patients in an Iranian department of internal medicine

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 2, 2009, Pages 104-110

  Pourseyed, Sara ^a   Fattahi, Fatemeh ^a   Pourpak, Zahra ^a   Gholami, Keirollah ^b   Shariatpanahi, Seyed Shamsa ^c   Moin, Athar ^c   Kazemnejad, Anoushirvan ^d   Moin, Mostafa ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHED UNIVERSITY   (Iran)

^d TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Adult; Adverse drug reaction; Internal medicine

Indexed keywords

ANTIALLERGIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; CONTRACEPTIVE AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; EPIRUBICIN; FLUOROURACIL; GEMFIBROZIL; GLIBENCLAMIDE; HORMONE DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; IOHEXOL; ISONIAZID; ISOPHANE INSULIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RIFAMPICIN; SIMVASTATIN; TRAMADOL;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIARRHEA; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG SURVEILLANCE PROGRAM; FEMALE; GASTROENTERITIS; GASTROINTESTINAL DISEASE; HEADACHE; HEART ARREST; HEART INFARCTION; HEART VENTRICLE FIBRILLATION; HEPATITIS; HOSPITAL ADMISSION; HUMAN; HYPERLIPIDEMIA; HYPOGLYCEMIA; HYPOTENSION; INTERNAL MEDICINE; IRAN; LEUKOPENIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; MORBIDITY; MYOPATHY; OBSERVATIONAL STUDY; PALLIATIVE THERAPY; PANCYTOPENIA; PATIENT COMPLIANCE; PHARMACIST ATTITUDE; PREDICTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; THROMBOCYTOPENIA; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT; DRUG TOXICITY; HOSPITAL DEPARTMENT; HOSPITALIZATION; MIDDLE AGED; PROSPECTIVE STUDY; STATISTICS; UNIVERSITY HOSPITAL;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; DRUG TOXICITY; FEMALE; HOSPITAL DEPARTMENTS; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; IRAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 62649140263     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1663     Document Type: Article

References (31)

1. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255-1259.
2. Pourpak Z, Fazlollahi MR, Fattahi F. Understanding adverse drug reaction and drug allergies: principle, diagnosis and treatment aspects. Recent Patents Inflamm Drug Discov 2008; 2: 24-46.
3. Fattinger K, Roos M, Vergeres P, et al. Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. Br J Clin Pharmacol 2000; 49: 158-167.
4. Mjorndal T, Boman MD, Hagg S, et al. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 2002; 11: 65-72.
5. Wasserfallen J, Livio F, Buclin T, Tillet L, Yersin B, Biollaz J. Rate, type, and cost of adverse drug reactions in emergency department admissions. Eur J Intern Med 2001; 12: 442-447.
6. Lacoste-Roussillon C, Pouyanne P, Haramburu F, Miremont G, Begaud B. Incidence of serious adverse drug reactions in general practice: a prospective study. Clin Pharmacol Ther 2001; 69: 458-462.
7. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998; 45: 301-308.
8. Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Begaud B. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 2000; 55: 181-186.
9. Routledge PA, O'Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2003; 57: 121-126.
10. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205.
11. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001; 52: 77-83.
12. Jonville-Bera AP, Giraudeau B, Blanc P, Beau-Salinas F, Autret-Leca E. Frequency of adverse drug reactions in children: a prospective study. Br J Clin Pharmacol 2002; 53: 207-210.
13. Somers A, Petrovic M, Robays H, Bogaert M. Reporting adverse drug reactions on a geriatric ward: a pilot project. Eur J Clin Pharmacol 2003; 58: 707-714.
14. Zoppi M, Braunschweig S, Kuenzi UP, Maibach R, Hoigne R. Incidence of lethal adverse drug reactions in the comprehensive hospital drug monitoring, a 20-year survey, 1974-1993, based on the data of Berne/St. Gallen. Eur J Clin Pharmacol 2000; 56: 427-430.
15. Essential Medicines: WHO Model List (Revised March 2005)- Explanatory Notes. (14th edn), March 2005.
16. Word Health Organization Collaborating Center for International Drug Monitoring of Adverse Reaction Terminology. Uppsala, 2002.
17. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992; 27: 538.
18. Fattahi F, Pourpak Z, Moin M, et al. Adverse drug reactions in hospitalized children in a department of infectious diseases. J Clin Pharmacol 2005; 45: 1313-1318.
19. Goettler M, Schneeweiss S, Hasford J. Adverse drug reaction monitoring-cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf 1997; 6: 79-90.
20. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199-205.
21. Lepori V, Perren A, Marone C. Adverse internal medicine drug effects at hospital admission. Schweiz Med Wochenschr 1999; 129: 915-922.
22. Camargo AL, Cardoso Ferreira MB, Heineck I. Adverse drug reactions: a cohort study in internal medicine units at a university hospital. Eur J Clin Pharmacol 2006; 62: 143-149.
23. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15-19.
24. Roughead EE, Gilbert AL, Primrose JG, Sansom LN. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust 1998; 168: 405-408.
25. von Euler M, Eliasson E, Ohlén G, Bergman U. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf 2006; 15: 179-184.
26. Tavassoli N, Bagheri H, Sailler L, Benkemoun P, Montastruc JL, Arlet P. Estimation of time devoted to adverse drug reactions assessment in an internal medicine department. Br J Clin Pharmacol 2005; 60: 452-453.
27. Tribiño G, Maldonado C, Segura O, Díaz J. Direct costs and clinical aspects of adverse drug reactions in patients admitted to a level 3 hospital internal medicine ward. Biomedica 2006; 26: 31-41.
28. Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother 1999; 33: 236-240.
29. Bhalla N, Duggan C, Dhillon S. The incidence and nature of drug-related admissions to hospital. Pharm J 2003; 270: 583-586.
30. Janaje Munasinghe TM, Singer DR. Costs and prevention of adverse drug reactions. Eur J Intern Med 2001; 12: 403-405.
31. Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital - their severity and cost involved. Pharmacoepidemiol Drug Saf 2003; 12: 687-692.